IQVIA Holdings Inc. (IQV)

NYSE: IQV · IEX Real-Time Price · USD
240.95 -3.45 (-1.41%)
Jan 21, 2022 4:03 PM EST - Market closed

Company Description

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific.

It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.

This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level.

The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services.

The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services.

It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. IQVIA has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017.

IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

IQVIA Holdings Inc.
IQVIA Holdings Logo
CountryUnited States
Founded1982
IPO DateMay 9, 2013
IndustryLife Sciences Tools & Services
SectorHealth Care
Employees77,000
CEOAri Bousbib

Contact Details

Address:
4820 Emperor Blvd
Durham, North Carolina 27703-8426
United States
Phone919 998 2000
Websiteiqvia.com

Stock Details

Ticker SymbolIQV
ExchangeNYSE
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
CIK Code0001478242

Key Executives

NamePosition
Ari BousbibChairman, President and Chief Executive Officer
Ronald E. BruehlmanExecutive Vice President and Chief Financial Officer
Kevin C. KnightlyPresident of Technology and Commercial Solutions
Eric M. SherbetExecutive Vice President, General Counsel and Secretary
W. Richard Staub IIIPresident of Research & Development Solutions
Emmanuel N. KorakisSenior Vice President, Corporate Controller and Principal Accounting Officer
Dr. Jeffrey A. SpaederSenior Vice President, Global Chief Medical and Scientific Officer
Alejandro MartinezChief Information Officer
Andrew MarkwickSenior Vice President of Investor Relations and Treasury
Nicholas ChildsSenior Vice President, Investor Relations and Corporate Communications

Latest SEC Filings

DateTypeTitle
Dec 23, 20214Statement of changes in beneficial ownership of securities
Dec 3, 20214Statement of changes in beneficial ownership of securities
Dec 1, 20214Statement of changes in beneficial ownership of securities
Oct 22, 202110-QQuarterly report [Sections 13 or 15(d)]
Oct 21, 20218-KCurrent report
Aug 25, 20218-KCurrent report
Aug 18, 20214Statement of changes in beneficial ownership of securities
Aug 5, 20214Statement of changes in beneficial ownership of securities
Jul 28, 202110-QQuarterly report [Sections 13 or 15(d)]
Jul 27, 20218-KCurrent report
View All SEC Filings